Susan Buchbinder, MD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address1001 Potrero Avenue, #4010
San Francisco CA 94110
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2025 02 18; 333(7):609-628. Gandhi RT, Landovitz RJ, Sax PE, Smith DM, Springer SA, Günthard HF, Thompson MA, Bedimo RJ, Benson CA, Buchbinder SP, Crabtree-Ramirez BE, Del Rio C, Eaton EF, Eron JJ, Hoy JF, Lehmann C, Molina JM, Jacobsen DM, Saag MS. PMID: 39616604.
      View in: PubMed   Mentions:    Fields:    
    2. Doxycycline Postexposure Prophylaxis and Sexually Transmitted Infection Trends. JAMA Intern Med. 2025 Jan 06. Sankaran M, Glidden DV, Kohn RP, Nguyen TQ, Bacon O, Buchbinder SP, Gandhi M, Havlir DV, Liebi C, Luetkemeyer AF, Nguyen JQ, Roman J, Scott H, Torres TS, Cohen SE. PMID: 39761052.
      View in: PubMed   Mentions:    Fields:    
    3. Rapid biphasic decay of intact and defective HIV DNA reservoir during acute treated HIV disease. Nat Commun. 2024 Nov 18; 15(1):9966. Barbehenn A, Shi L, Shao J, Hoh R, Hartig HM, Pae V, Sarvadhavabhatla S, Donaire S, Sheikhzadeh C, Milush J, Laird GM, Mathias M, Ritter K, Peluso MJ, Martin J, Hecht F, Pilcher C, Cohen SE, Buchbinder S, Havlir D, Gandhi M, Henrich TJ, Hatano H, Wang J, Deeks SG, Lee SA. PMID: 39557853; PMCID: PMC11574060.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    4. Evidence-Informed Provision of Doxycycline Post-Exposure Prophylaxis for Prevention of Bacterial Sexually Transmitted Infections. Clin Infect Dis. 2024 Oct 30. Dombrowski JC, Donnell D, Grabow C, Cohen SE, Cannon CA, Brown CE, Buchbinder SP, Celum C, Luetkemeyer AF. PMID: 39478321.
      View in: PubMed   Mentions:    Fields:    
    5. Acceptability of an automated directly observed therapy (DOT) application for PrEP adherence support among young men who have sex with men: a qualitative exploration. AIDS Care. 2024 Nov; 36(11):1704-1718. Velloza J, Liu AY, Katz AWK, van der Straten A, Siegler AJ, Scott H, Wilde G, Lockard A, Christie RH, Buchbinder SP. PMID: 39222964; PMCID: PMC11511627.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    6. Rapid Biphasic Decay of Intact and Defective HIV DNA Reservoir During Acute Treated HIV Disease. medRxiv. 2024 Aug 22. Barbehenn A, Shi L, Shao J, Hoh R, Hartig HM, Pae V, Sarvadhavabhatla S, Donaire S, Sheikhzadeh C, Milush J, Laird GM, Mathias M, Ritter K, Peluso MJ, Martin J, Hecht F, Pilcher C, Cohen SE, Buchbinder S, Havlir D, Gandhi M, Henrich TJ, Hatano H, Wang J, Deeks SG, Lee SA. PMID: 38585951; PMCID: PMC10996734.
      View in: PubMed   Mentions:
    7. CROI 2024: Global Epidemiology and Prevention of HIV and Other Sexually Transmitted Diseases. Top Antivir Med. 2024 Jul 17; 32(3):447-482. Liu AY, Buchbinder SP. PMID: 39142289; PMCID: PMC11293602.
      View in: PubMed   Mentions:
    8. Point-of-care urine tenofovir test predicts future HIV preexposure prophylaxis discontinuation among young users. AIDS. 2024 Sep 01; 38(11):1671-1676. Martinson T, Montoya R, Moreira C, Kuncze K, Sassaman K, Heise MJ, Glidden DV, Amico KR, Arnold EA, Buchbinder SP, Ewart LD, Carrico A, Wang G, Okochi H, Scott HM, Gandhi M, Spinelli MA. PMID: 38905507; PMCID: PMC11293961.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    9. New USPSTF Guidelines for HIV Preexposure Prophylaxis: Will More Choices Lead to Greater Impact? JAMA. 2023 08 22; 330(8):699-701. Liu AY, Scott HM, Buchbinder SP. PMID: 37606684; PMCID: PMC10586231.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    10. CROI 2023: Epidemiologic Trends and Prevention for HIV and Other Sexually Transmitted Infections. Top Antivir Med. 2023 May; 31(3):468-492. Liu AY, Buchbinder SP. PMID: 37315512; PMCID: PMC10266866.
      View in: PubMed   Mentions:
    11. Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections. N Engl J Med. 2023 Apr 06; 388(14):1296-1306. Luetkemeyer AF, Donnell D, Dombrowski JC, Cohen S, Grabow C, Brown CE, Malinski C, Perkins R, Nasser M, Lopez C, Vittinghoff E, Buchbinder SP, Scott H, Charlebois ED, Havlir DV, Soge OO, Celum C, DoxyPEP Study Team. PMID: 37018493; PMCID: PMC10140182.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansPHPublic Health
    12. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2023 01 03; 329(1):63-84. Gandhi RT, Bedimo R, Hoy JF, Landovitz RJ, Smith DM, Eaton EF, Lehmann C, Springer SA, Sax PE, Thompson MA, Benson CA, Buchbinder SP, Del Rio C, Eron JJ, Günthard HF, Molina JM, Jacobsen DM, Saag MS. PMID: 36454551.
      View in: PubMed   Mentions: 133     Fields:    Translation:HumansCells
    13. Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens. EBioMedicine. 2022 Oct; 84:104271. Huang Y, Zhang Y, Seaton KE, De Rosa S, Heptinstall J, Carpp LN, Randhawa AK, McKinnon LR, McLaren P, Viegas E, Gray GE, Churchyard G, Buchbinder SP, Edupuganti S, Bekker LG, Keefer MC, Hosseinipour MC, Goepfert PA, Cohen KW, Williamson BD, McElrath MJ, Tomaras GD, Thakar J, Kobie JJ, NIAID HIV Vaccine Trials Network (HVTN) 073/South African AIDS Vaccine Initiative (SAAVI) 102, HVTN . PMID: 36179551; PMCID: PMC9520208.
      View in: PubMed   Mentions:
    14. Impact of Multicomponent Support Strategies on Human Immunodeficiency Virus Virologic Suppression Rates During Coronavirus Disease 2019: An Interrupted Time Series Analysis. Clin Infect Dis. 2022 08 24; 75(1):e947-e954. Spinelli MA, Le Tourneau N, Glidden DV, Hsu L, Hickey MD, Imbert E, Arreguin M, Jain JP, Oskarsson JJ, Buchbinder SP, Johnson MO, Havlir D, Christopoulos KA, Gandhi M. PMID: 35245934; PMCID: PMC9129130.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsPHPublic Health
    15. Randomized Controlled Trial of Automated Directly Observed Therapy for Measurement and Support of PrEP Adherence Among Young Men Who have Sex with Men. AIDS Behav. 2023 Feb; 27(2):719-732. Buchbinder SP, Siegler AJ, Coleman K, Vittinghoff E, Wilde G, Lockard A, Scott H, Anderson PL, Laborde N, van der Straten A, Christie RH, Marlborough M, Liu AY. PMID: 35984607; PMCID: PMC9908647.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    16. Effect of Social Determinants of Health on Uncontrolled Human Immunodeficiency Virus (HIV) Infection Among Persons With HIV in San Francisco, California. Open Forum Infect Dis. 2022 Jul; 9(7):ofac312. Melo JS, Hessol NA, Pipkin S, Buchbinder SP, Hsu LC. PMID: 35899287; PMCID: PMC9310268.
      View in: PubMed   Mentions: 5  
    17. COVID-19 vaccination and HIV-1 acquisition - Authors' reply. Lancet. 2022 04 09; 399(10333):e36. Buchbinder SP, McElrath MJ, Dieffenbach C, Corey L. PMID: 35397867; PMCID: PMC8989399.
      View in: PubMed   Mentions:
    18. SARS-CoV-2 incidence, testing rates, and severe COVID-19 outcomes among people with and without HIV. AIDS. 2021 12 01; 35(15):2545-2547. Spinelli MA, Brown LB, Glidden DV, Hunter K, Martin-Tuite P, Zheng J, Sera C, Havlir D, Buchbinder SP, Gandhi M. PMID: 34870933; PMCID: PMC8673488.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    19. Development of a Citywide Rapid Antiretroviral Therapy Initiative in San Francisco. Am J Prev Med. 2021 11; 61(5 Suppl 1):S47-S54. Bacon OML, Coffey SC, Hsu LC, Chin JCS, Havlir DV, Buchbinder SP. PMID: 34686290.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    20. Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine. N Engl J Med. 2021 12 16; 385(25):2348-2360. Falsey AR, Sobieszczyk ME, Hirsch I, Sproule S, Robb ML, Corey L, Neuzil KM, Hahn W, Hunt J, Mulligan MJ, McEvoy C, DeJesus E, Hassman M, Little SJ, Pahud BA, Durbin A, Pickrell P, Daar ES, Bush L, Solis J, Carr QO, Oyedele T, Buchbinder S, Cowden J, Vargas SL, Guerreros Benavides A, Call R, Keefer MC, Kirkpatrick BD, Pullman J, Tong T, Brewinski Isaacs M, Benkeser D, Janes HE, Nason MC, Green JA, Kelly EJ, Maaske J, Mueller N, Shoemaker K, Takas T, Marshall RP, Pangalos MN, Villafana T, Gonzalez-Lopez A, AstraZeneca AZD1222 Clinical Study Group. PMID: 34587382; PMCID: PMC8522798.
      View in: PubMed   Mentions: 337     Fields:    Translation:HumansCellsCTClinical Trials
    21. CROI 2021: Epidemiologic Trends in the HIV and SARS-CoV-2 Pandemics and HIV Prevention Research. Top Antivir Med. 2021 Apr-May; 29(2):309-327. Buchbinder S, Liu A. PMID: 34107201; PMCID: PMC8224247.
      View in: PubMed   Mentions:
    22. Sensitivity and Specificity of the National Death Index for Multiple Causes of Death in People With HIV. Public Health Rep. 2021 Sep-Oct; 136(5):595-602. Schwarcz S, Hessol NA, Spinelli MA, Hsu LC, Wlodarczyk D, Tulsky J, Newman MD, Buchbinder SP. PMID: 33541227; PMCID: PMC8361560.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    23. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2020 10 27; 324(16):1651-1669. Saag MS, Gandhi RT, Hoy JF, Landovitz RJ, Thompson MA, Sax PE, Smith DM, Benson CA, Buchbinder SP, Del Rio C, Eron JJ, Fätkenheuer G, Günthard HF, Molina JM, Jacobsen DM, Volberding PA. PMID: 33052386; PMCID: PMC11017368.
      View in: PubMed   Mentions: 171     Fields:    Translation:HumansCellsPHPublic Health
    24. HLA tapasin independence: broader peptide repertoire and HIV control. Proc Natl Acad Sci U S A. 2020 11 10; 117(45):28232-28238. Bashirova AA, Viard M, Naranbhai V, Grifoni A, Garcia-Beltran W, Akdag M, Yuki Y, Gao X, O'hUigin C, Raghavan M, Wolinsky S, Bream JH, Duggal P, Martinson J, Michael NL, Kirk GD, Buchbinder SP, Haas D, Goedert JJ, Deeks SG, Fellay J, Walker B, Goulder P, Cresswell P, Elliott T, Sette A, Carlson J, Carrington M. PMID: 33097667; PMCID: PMC7668082.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    25. Use of adenovirus type-5 vectored vaccines: a cautionary tale. Lancet. 2020 10 31; 396(10260):e68-e69. Buchbinder SP, McElrath MJ, Dieffenbach C, Corey L. PMID: 33091364; PMCID: PMC7571904.
      View in: PubMed   Mentions:
    26. Understanding PrEP Persistence: Provider and Patient Perspectives. AIDS Behav. 2020 Sep; 24(9):2509-2519. Laborde ND, Kinley PM, Spinelli M, Vittinghoff E, Whitacre R, Scott HM, Buchbinder SP. PMID: 32048078; PMCID: PMC8054778.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansPHPublic Health
    27. Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature. Sci Rep. 2020 08 03; 10(1):13031. Palli R, Seaton KE, Piepenbrink MS, Hural J, Goepfert PA, Laher F, Buchbinder SP, Churchyard G, Gray GE, Robinson HL, Huang Y, Janes H, Kobie JJ, Keefer MC, Tomaras GD, Thakar J. PMID: 32747654; PMCID: PMC7398916.
      View in: PubMed   Mentions:
    28. The importance of PrEP persistence in preventing HIV infections on PrEP. J Int AIDS Soc. 2020 08; 23(8):e25578. Spinelli MA, Laborde N, Kinley P, Whitacre R, Scott HM, Walker N, Liu AY, Gandhi M, Buchbinder SP. PMID: 32844591; PMCID: PMC7448189.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    29. Pre-exposure Prophylaxis Persistence Is a Critical Issue in PrEP Implementation. Clin Infect Dis. 2020 07 27; 71(3):583-585. Spinelli MA, Buchbinder SP. PMID: 31509603; PMCID: PMC7384308.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansPHPublic Health
    30. Virtual CROI 2020: Highlights of Epidemiology, Public Health, and Prevention Research. Top Antivir Med. 2020 Jun; 28(2):439-454. Buchbinder SP, Liu AY. PMID: 32886464; PMCID: PMC7482984.
      View in: PubMed   Mentions:
    31. Missed opportunities to prevent HIV infections among pre-exposure prophylaxis users: a population-based mixed methods study, San Francisco, United States. J Int AIDS Soc. 2020 04; 23(4):e25472. Spinelli MA, Laborde N, Kinley P, Whitacre R, Scott HM, Walker N, Liu AY, Gandhi M, Buchbinder SP. PMID: 32294338; PMCID: PMC7159249.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansPHPublic Health
    32. Getting to Zero San Francisco: A Collective Impact Approach. J Acquir Immune Defic Syndr. 2019 12; 82 Suppl 3:S176-S182. Buchbinder SP, Havlir DV. PMID: 31764252; PMCID: PMC6880800.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansPHPublic Health
    33. Racial/ethnic and HIV risk category disparities in preexposure prophylaxis discontinuation among patients in publicly funded primary care clinics. AIDS. 2019 11 15; 33(14):2189-2195. Scott HM, Spinelli M, Vittinghoff E, Morehead-Gee A, Hirozawa A, James C, Hammer H, Liu A, Gandhi M, Buchbinder S. PMID: 31436610; PMCID: PMC6832847.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansPHPublic Health
    34. Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial. J Virol. 2019 11 01; 93(21). Li SS, Gilbert PB, Carpp LN, Pyo CW, Janes H, Fong Y, Shen X, Neidich SD, Goodman D, deCamp A, Cohen KW, Ferrari G, Hammer SM, Sobieszczyk ME, Mulligan MJ, Buchbinder SP, Keefer MC, DeJesus E, Novak RM, Frank I, McElrath MJ, Tomaras GD, Geraghty DE, Peng X. PMID: 31434737; PMCID: PMC6803257.
      View in: PubMed   Mentions:
    35. Evaluating the impact of policies recommending PrEP to subpopulations of men and transgender women who have sex with men based on demographic and behavioral risk factors. PLoS One. 2019; 14(9):e0222183. Janes H, Brown MD, Glidden DV, Mayer KH, Buchbinder SP, McMahan VM, Schechter M, Guanira J, Casapia M. PMID: 31536518; PMCID: PMC6752862.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    36. Homelessness at diagnosis is associated with death among people with HIV in a population-based study of a US city. AIDS. 2019 09 01; 33(11):1789-1794. Spinelli MA, Hessol NA, Schwarcz S, Hsu L, Parisi MK, Pipkin S, Scheer S, Havlir D, Buchbinder SP. PMID: 31259765; PMCID: PMC6663574.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    37. Ending AIDS in the United States-If Not Now, When? JAMA Intern Med. 2019 Sep 01; 179(9):1165-1166. Havlir DV, Buchbinder SP. PMID: 31184750.
      View in: PubMed   Mentions: 2     Fields:    
    38. Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration Project. AIDS Res Hum Retroviruses. 2019 09; 35(9):788-793. Spinelli MA, Glidden DV, Anderson PL, Gandhi M, McMahan VM, Defechereux P, Schechter M, Veloso VG, Chariyalertsak S, Guanira JV, Bekker LG, Buchbinder SP, Grant RM. PMID: 31119944; PMCID: PMC6735322.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    39. STIs: an unintended consequence of improved sexual health? Lancet HIV. 2019 07; 6(7):e415-e416. Scott HM, Buchbinder SP. PMID: 31178285.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    40. Brief Report: Short-Term Adherence Marker to PrEP Predicts Future Nonretention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing. J Acquir Immune Defic Syndr. 2019 06 01; 81(2):158-162. Spinelli MA, Glidden DV, Anderson PL, Gandhi M, Cohen S, Vittinghoff E, Coleman ME, Scott H, Bacon O, Elion R, Kolber MA, Buchbinder SP, Liu AY. PMID: 31095005; PMCID: PMC6530484.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansPHPublic Health
    41. Randomized Controlled Trial of a Mobile Health Intervention to Promote Retention and Adherence to Preexposure Prophylaxis Among Young People at Risk for Human Immunodeficiency Virus: The EPIC Study. Clin Infect Dis. 2019 05 30; 68(12):2010-2017. Liu AY, Vittinghoff E, von Felten P, Rivet Amico K, Anderson PL, Lester R, Andrew E, Estes I, Serrano P, Brothers J, Buchbinder S, Hosek S, Fuchs JD. PMID: 30239620; PMCID: PMC6541706.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansPHPublic Health
    42. The aspirational necessity of HIV prevention. J Int AIDS Soc. 2019 05; 22(5):e25289. Corey L, Gray GE, Buchbinder SP. PMID: 31099956; PMCID: PMC6524609.
      View in: PubMed   Mentions:
    43. Low tenofovir level in urine by a novel immunoassay is associated with seroconversion in a preexposure prophylaxis demonstration project. AIDS. 2019 04 01; 33(5):867-872. Spinelli MA, Glidden DV, Rodrigues WC, Wang G, Vincent M, Okochi H, Kuncze K, Mehrotra M, Defechereux P, Buchbinder SP, Grant RM, Gandhi M. PMID: 30649051; PMCID: PMC6375797.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansPHPublic Health
    44. High Interest in Doxycycline for Sexually Transmitted Infection Postexposure Prophylaxis in a Multicity Survey of Men Who Have Sex With Men Using a Social Networking Application. Sex Transm Dis. 2019 04; 46(4):e32-e34. Spinelli MA, Scott HM, Vittinghoff E, Liu AY, Coleman K, Buchbinder SP. PMID: 30870327; PMCID: PMC6425754.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    45. CROI 2019: advances in HIV prevention and plans to end the epidemic. Top Antivir Med. 2019 Apr; 27(1):8-25. Buchbinder SP, Liu AY. PMID: 31136999; PMCID: PMC6550360.
      View in: PubMed   Mentions:
    46. Housing Instability Results in Increased Acute Care Utilization in an Urban HIV Clinic Cohort. Open Forum Infect Dis. 2019 May; 6(5):ofz148. Clemenzi-Allen A, Neuhaus J, Geng E, Sachdev D, Buchbinder S, Havlir D, Gandhi M, Christopoulos K. PMID: 31139668; PMCID: PMC6534280.
      View in: PubMed   Mentions: 14  
    47. Missed Visits Associated With Future Preexposure Prophylaxis (PrEP) Discontinuation Among PrEP Users in a Municipal Primary Care Health Network. Open Forum Infect Dis. 2019 Apr; 6(4):ofz101. Spinelli MA, Scott HM, Vittinghoff E, Liu AY, Gonzalez R, Morehead-Gee A, Gandhi M, Buchbinder SP. PMID: 30949540; PMCID: PMC6441570.
      View in: PubMed   Mentions: 36  
    48. Brief Report: A Panel Management and Patient Navigation Intervention Is Associated With Earlier PrEP Initiation in a Safety-Net Primary Care Health System. J Acquir Immune Defic Syndr. 2018 11 01; 79(3):347-351. Spinelli MA, Scott HM, Vittinghoff E, Liu AY, Morehead-Gee A, Gonzalez R, Gandhi M, Buchbinder SP. PMID: 30085955; PMCID: PMC6185763.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansPHPublic Health
    49. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2018 07 24; 320(4):379-396. Saag MS, Benson CA, Gandhi RT, Hoy JF, Landovitz RJ, Mugavero MJ, Sax PE, Smith DM, Thompson MA, Buchbinder SP, Del Rio C, Eron JJ, Fätkenheuer G, Günthard HF, Molina JM, Jacobsen DM, Volberding PA. PMID: 30043070; PMCID: PMC6415748.
      View in: PubMed   Mentions: 254     Fields:    Translation:Humans
    50. Metabolic Effects of Preexposure Prophylaxis With Coformulated Tenofovir Disoproxil Fumarate and Emtricitabine. Clin Infect Dis. 2018 07 18; 67(3):411-419. Glidden DV, Mulligan K, McMahan V, Anderson PL, Guanira J, Chariyalertsak S, Buchbinder SP, Bekker LG, Schechter M, Grinsztejn B, Grant RM. PMID: 29415175; PMCID: PMC6051460.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansPHPublic Health
    51. Provider Adherence to Pre-exposure Prophylaxis Monitoring Guidelines in a Large Primary Care Network. Open Forum Infect Dis. 2018 Jun; 5(6):ofy099. Spinelli MA, Scott HM, Vittinghoff E, Liu AY, Morehead-Gee A, Gonzalez R, Buchbinder SP. PMID: 29977959; PMCID: PMC6016415.
      View in: PubMed   Mentions: 14  
    52. CROI 2018: Epidemic Trends and Advances in HIV Prevention. Top Antivir Med. 2018 May; 26(1):1-16. Buchbinder SP, Liu AY. PMID: 29727292; PMCID: PMC5963932.
      View in: PubMed   Mentions:
    53. Maximizing the Benefits of HIV Preexposure Prophylaxis. Top Antivir Med. 2018 Apr; 25(4):138-142. Buchbinder SP. PMID: 29689539; PMCID: PMC5935218.
      View in: PubMed   Mentions:
    54. Degree of Housing Instability Shows Independent "Dose-Response" With Virologic Suppression Rates Among People Living With Human Immunodeficiency Virus. Open Forum Infect Dis. 2018 Mar; 5(3):ofy035. Clemenzi-Allen A, Geng E, Christopoulos K, Hammer H, Buchbinder S, Havlir D, Gandhi M. PMID: 29577059; PMCID: PMC5850870.
      View in: PubMed   Mentions: 30  
    55. A Mobile Health Strategy to Support Adherence to Antiretroviral Preexposure Prophylaxis. AIDS Patient Care STDS. 2018 03; 32(3):104-111. Fuchs JD, Stojanovski K, Vittinghoff E, McMahan VM, Hosek SG, Amico KR, Kouyate A, Gilmore HJ, Buchbinder SP, Lester RT, Grant RM, Liu AY. PMID: 29565183; PMCID: PMC5865612.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansPHPublic Health
    56. Changes in Kidney Function Associated With Daily Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Preexposure Prophylaxis Use in the United States Demonstration Project. J Acquir Immune Defic Syndr. 2018 02 01; 77(2):193-198. Tang EC, Vittinghoff E, Anderson PL, Cohen SE, Doblecki-Lewis S, Bacon O, Coleman ME, Buchbinder SP, Chege W, Kolber MA, Elion R, Shlipak M, Liu AY. PMID: 28991887; PMCID: PMC5762266.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansPHPublic Health
    57. Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial. PLoS One. 2018; 13(1):e0190118. Baxi SM, Vittinghoff E, Bacchetti P, Huang Y, Chillag K, Wiegand R, Anderson PL, Grant R, Greenblatt RM, Buchbinder S, Gandhi M, Liu AY. PMID: 29315307; PMCID: PMC5760024.
      View in: PubMed   Mentions: 15     Fields:    Translation:PHPublic Health
    58. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study. PLoS Med. 2017 Nov; 14(11):e1002417. Henrich TJ, Hatano H, Bacon O, Hogan LE, Rutishauser R, Hill A, Kearney MF, Anderson EM, Buchbinder SP, Cohen SE, Abdel-Mohsen M, Pohlmeyer CW, Fromentin R, Hoh R, Liu AY, McCune JM, Spindler J, Metcalf-Pate K, Hobbs KS, Thanh C, Gibson EA, Kuritzkes DR, Siliciano RF, Price RW, Richman DD, Chomont N, Siliciano JD, Mellors JW, Yukl SA, Blankson JN, Liegler T, Deeks SG. PMID: 29112956; PMCID: PMC5675377.
      View in: PubMed   Mentions: 128     Fields:    Translation:HumansCellsPHPublic Health
    59. Hair levels of preexposure prophylaxis drugs measure adherence and are associated with renal decline among men/transwomen. AIDS. 2017 Oct 23; 31(16):2245-2251. Gandhi M, Murnane PM, Bacchetti P, Elion R, Kolber MA, Cohen SE, Horng H, Louie A, Kuncze K, Koss CA, Anderson PL, Buchbinder S, Liu A. PMID: 28832411; PMCID: PMC5633521.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansPHPublic Health
    60. Brief Report: Recovery of Bone Mineral Density After Discontinuation of Tenofovir-Based HIV Pre-exposure Prophylaxis. J Acquir Immune Defic Syndr. 2017 10 01; 76(2):177-182. Glidden DV, Mulligan K, McMahan V, Anderson PL, Guanira J, Chariyalertsak S, Buchbinder SP, Bekker LG, Schechter M, Grinsztejn B, Grant RM. PMID: 28639995; PMCID: PMC5597476.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    61. Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults. PLoS One. 2017; 12(7):e0179597. Buchbinder SP, Grunenberg NA, Sanchez BJ, Seaton KE, Ferrari G, Moody MA, Frahm N, Montefiori DC, Hay CM, Goepfert PA, Baden LR, Robinson HL, Yu X, Gilbert PB, McElrath MJ, Huang Y, Tomaras GD, HIV Vaccine Trials Network (HVTN) 094 Study Group. PMID: 28727817; PMCID: PMC5519050.
      View in: PubMed   Mentions:
    62. Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial. J Infect Dis. 2017 05 01; 215(9):1376-1385. Janes HE, Cohen KW, Frahm N, De Rosa SC, Sanchez B, Hural J, Magaret CA, Karuna S, Bentley C, Gottardo R, Finak G, Grove D, Shen M, Graham BS, Koup RA, Mulligan MJ, Koblin B, Buchbinder SP, Keefer MC, Adams E, Anude C, Corey L, Sobieszczyk M, Hammer SM, Gilbert PB, McElrath MJ. PMID: 28199679; PMCID: PMC5853653.
      View in: PubMed   Mentions:
    63. International Sexual Partnerships May Be Shaped by Sexual Histories and Socioeconomic Status. Sex Transm Dis. 2017 05; 44(5):306-309. Truong HM, Mehrotra M, Montoya O, Lama JR, Guanira JV, Casapía M, Veloso VG, Buchbinder SP, Mayer KH, Chariyalertsak S, Schechter M, Bekker LG, Kallás EG, Grant RM. PMID: 28407648; PMCID: PMC5407391.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    64. CROI 2017: HIV Epidemic Trends and Advances in Prevention. Top Antivir Med. 2017 May/Jun; 25(2):35-50. Liu AY, Buchbinder SP. PMID: 28598789; PMCID: PMC5677042.
      View in: PubMed   Mentions:
    65. Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort study. Lancet HIV. 2016 11; 3(11):e521-e528. Gandhi M, Glidden DV, Mayer K, Schechter M, Buchbinder S, Grinsztejn B, Hosek S, Casapia M, Guanira J, Bekker LG, Louie A, Horng H, Benet LZ, Liu A, Grant RM. PMID: 27658870; PMCID: PMC5085869.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    66. Sexual Behavior, Risk Compensation, and HIV Prevention Strategies Among Participants in the San Francisco PrEP Demonstration Project: A Qualitative Analysis of Counseling Notes. AIDS Behav. 2016 07; 20(7):1461-9. Carlo Hojilla J, Koester KA, Cohen SE, Buchbinder S, Ladzekpo D, Matheson T, Liu AY. PMID: 25835463; PMCID: PMC4592687.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansPHPublic Health
    67. CROI 2016: Hot Spots in HIV Infection and Advances in HIV Prevention. Top Antivir Med. 2016 May-Jun; 24(1):10-28. Buchbinder SP, Liu AY. PMID: 27398859; PMCID: PMC6148926.
      View in: PubMed   Mentions:
    68. Acceptability and Feasibility of HIV Self-Testing Among Transgender Women in San Francisco: A Mixed Methods Pilot Study. AIDS Behav. 2016 Apr; 20(4):928-38. Lippman SA, Moran L, Sevelius J, Castillo LS, Ventura A, Treves-Kagan S, Buchbinder S. PMID: 26511864; PMCID: PMC4799740.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansPHPublic Health
    69. Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension. Clin Infect Dis. 2016 May 01; 62(9):1172-7. Glidden DV, Amico KR, Liu AY, Hosek SG, Anderson PL, Buchbinder SP, McMahan V, Mayer KH, David B, Schechter M, Grinsztejn B, Guanira J, Grant RM. PMID: 26797207; PMCID: PMC4826449.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    70. Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services. JAMA Intern Med. 2016 Jan; 176(1):75-84. Liu AY, Cohen SE, Vittinghoff E, Anderson PL, Doblecki-Lewis S, Bacon O, Chege W, Postle BS, Matheson T, Amico KR, Liegler T, Rawlings MK, Trainor N, Blue RW, Estrada Y, Coleman ME, Cardenas G, Feaster DJ, Grant R, Philip SS, Elion R, Buchbinder S, Kolber MA. PMID: 26571482; PMCID: PMC5042323.
      View in: PubMed   Mentions: 337     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    71. Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083. J Infect Dis. 2016 Feb 15; 213(4):541-50. Walsh SR, Moodie Z, Fiore-Gartland AJ, Morgan C, Wilck MB, Hammer SM, Buchbinder SP, Kalams SA, Goepfert PA, Mulligan MJ, Keefer MC, Baden LR, Swann EM, Grant S, Ahmed H, Li F, Hertz T, Self SG, Friedrich D, Frahm N, Liao HX, Montefiori DC, Tomaras GD, McElrath MJ, Hural J, Graham BS, Jin X, HVTN 083 Study Group and the NIAID HVTN. PMID: 26475930; PMCID: PMC4721914.
      View in: PubMed   Mentions:
    72. HIV infection. Nat Rev Dis Primers. 2015 10 01; 1:15035. Deeks SG, Overbaugh J, Phillips A, Buchbinder S. PMID: 27188527.
      View in: PubMed   Mentions: 227     Fields:    Translation:HumansCells
    73. Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials. PLoS One. 2015; 10(9):e0136626. Huang Y, Follmann D, Nason M, Zhang L, Huang Y, Mehrotra DV, Moodie Z, Metch B, Janes H, Keefer MC, Churchyard G, Robb ML, Fast PE, Duerr A, McElrath MJ, Corey L, Mascola JR, Graham BS, Sobieszczyk ME, Kublin JG, Robertson M, Hammer SM, Gray GE, Buchbinder SP, Gilbert PB. PMID: 26332672; PMCID: PMC4558095.
      View in: PubMed   Mentions:
    74. Authors' Reply: Race and the Public Health Impact Potential of Pre-Exposure Prophylaxis in the United States. J Acquir Immune Defic Syndr. 2015 Sep 01; 70(1):e33-5. Cohen SE, Vittinghoff E, Doblecki-Lewis S, Coleman M, Bacon O, Elion R, Kolber MA, Buchbinder S, Liu AY. PMID: 26049284; PMCID: PMC4558271.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    75. HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders. Nat Med. 2015 Oct; 21(10):1139-41. Janes H, Herbeck JT, Tovanabutra S, Thomas R, Frahm N, Duerr A, Hural J, Corey L, Self SG, Buchbinder SP, McElrath MJ, O'Connell RJ, Paris RM, Rerks-Ngarm S, Nitayaphan S, Pitisuttihum P, Kaewkungwal J, Robb ML, Michael NL, Mullins JI, Kim JH, Gilbert PB, Rolland M. PMID: 26322580; PMCID: PMC4598284.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    76. First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090). Open Forum Infect Dis. 2015 Sep; 2(3):ofv082. Fuchs JD, Frank I, Elizaga ML, Allen M, Frahm N, Kochar N, Li S, Edupuganti S, Kalams SA, Tomaras GD, Sheets R, Pensiero M, Tremblay MA, Higgins TJ, Latham T, Egan MA, Clarke DK, Eldridge JH, HVTN 090 Study Group and the National Institutes of Allergy and Infectious Diseases HIV Vaccine Tria, Mulligan M, Rouphael N, Estep S, Rybczyk K, Dunbar D, Buchbinder S, Wagner T, Isbell R, Chinnell V, Bae J, Escamilla G, Tseng J, Fair R, Ramirez S, Broder G, Briesemeister L, Ferrara A. PMID: 26199949; PMCID: PMC4504730.
      View in: PubMed   Mentions: 42  
    77. Targeting pre-exposure prophylaxis among men who have sex with men in the United States and Peru: partnership types, contact rates, and sexual role. J Acquir Immune Defic Syndr. 2015 May 01; 69(1):119-25. Carnegie NB, Goodreau SM, Liu A, Vittinghoff E, Sanchez J, Lama JR, Buchbinder S. PMID: 25942463; PMCID: PMC4422184.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansPHPublic Health
    78. Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial. Clin Infect Dis. 2015 Aug 15; 61(4):572-80. Mulligan K, Glidden DV, Anderson PL, Liu A, McMahan V, Gonzales P, Ramirez-Cardich ME, Namwongprom S, Chodacki P, de Mendonca LM, Wang F, Lama JR, Chariyalertsak S, Guanira JV, Buchbinder S, Bekker LG, Schechter M, Veloso VG, Grant RM, Preexposure Prophylaxis Initiative Study Team. PMID: 25908682; PMCID: PMC4565984.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCells
    79. High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project. J Acquir Immune Defic Syndr. 2015 Apr 01; 68(4):439-48. Cohen SE, Vittinghoff E, Bacon O, Doblecki-Lewis S, Postle BS, Feaster DJ, Matheson T, Trainor N, Blue RW, Estrada Y, Coleman ME, Elion R, Castro JG, Chege W, Philip SS, Buchbinder S, Kolber MA, Liu AY. PMID: 25501614; PMCID: PMC4334721.
      View in: PubMed   Mentions: 123     Fields:    Translation:HumansPHPublic Health
    80. Client and provider perspectives on new HIV prevention tools for MSM in the Americas. PLoS One. 2015; 10(3):e0121044. Lippman SA, Koester KA, Amico KR, Lama JR, Martinez Fernandes N, Gonzales P, Grinsztejn B, Liu A, Buchbinder S, Koblin BA. PMID: 25826246; PMCID: PMC4380356.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    81. CROI 2015: Advances in HIV Testing and Prevention Strategies. Top Antivir Med. 2015 Mar-Apr; 23(1):8-27. Buchbinder SP, Liu AY. PMID: 25965309; PMCID: PMC6148903.
      View in: PubMed   Mentions:
    82. Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study. J Acquir Immune Defic Syndr. 2014 Dec 15; 67(5):528-37. Liu A, Glidden DV, Anderson PL, Amico KR, McMahan V, Mehrotra M, Lama JR, MacRae J, Hinojosa JC, Montoya O, Veloso VG, Schechter M, Kallas EG, Chariyalerstak S, Bekker LG, Mayer K, Buchbinder S, Grant R, iPrEx Study team. PMID: 25230290; PMCID: PMC4229454.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansPHPublic Health
    83. Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation. AIDS Patient Care STDS. 2014 Dec; 28(12):622-7. Liu AY, Hessol NA, Vittinghoff E, Amico KR, Kroboth E, Fuchs J, Irvin R, Sineath RC, Sanchez T, Sullivan PS, Buchbinder SP. PMID: 25396706; PMCID: PMC4250955.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansPHPublic Health
    84. Infrequent HIV testing and late HIV diagnosis are common among a cohort of black men who have sex with men in 6 US cities. J Acquir Immune Defic Syndr. 2014 Dec 01; 67(4):438-45. Mannheimer SB, Wang L, Wilton L, Van Tieu H, Del Rio C, Buchbinder S, Fields S, Glick S, Connor MB, Cummings V, Eshleman SH, Koblin B, Mayer KH. PMID: 25197830; PMCID: PMC4213315.
      View in: PubMed   Mentions:
    85. Low-level Viremia early in HIV infection. J Acquir Immune Defic Syndr. 2014 Dec 01; 67(4):405-8. Chen I, Cummings V, Fogel JM, Marzinke MA, Clarke W, Connor MB, Griffith S, Buchbinder S, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH. PMID: 25140905; PMCID: PMC4213245.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    86. Long-chain peer referral to recruit black MSM and black transgender women for an HIV vaccine efficacy trial. J Acquir Immune Defic Syndr. 2014 Aug 01; 66(4):e94-7. Coombs A, McFarland W, Ick T, Fuqua V, Buchbinder SP, Fuchs JD. PMID: 24815850; PMCID: PMC4118575.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    87. Can male circumcision have an impact on the HIV epidemic in men who have sex with men? PLoS One. 2014; 9(7):e102960. Goodreau SM, Carnegie NB, Vittinghoff E, Lama JR, Fuchs JD, Sanchez J, Buchbinder SP. PMID: 25076493; PMCID: PMC4116164.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    88. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014 Sep; 14(9):820-9. Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, Hosek S, Mosquera C, Casapia M, Montoya O, Buchbinder S, Veloso VG, Mayer K, Chariyalertsak S, Bekker LG, Kallas EG, Schechter M, Guanira J, Bushman L, Burns DN, Rooney JF, Glidden DV, iPrEx study team. PMID: 25065857; PMCID: PMC6107918.
      View in: PubMed   Mentions: 685     Fields:    Translation:Humans
    89. A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation. PLoS One. 2014; 9(6):e101043. Cousins MM, Konikoff J, Sabin D, Khaki L, Longosz AF, Laeyendecker O, Celum C, Buchbinder SP, Seage GR, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Kobin BA, Wheeler D, Justman JE, Hodder SL, Quinn TC, Brookmeyer R, Eshleman SH. PMID: 24968135; PMCID: PMC4072769.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    90. CROI 2014: New tools to track the epidemic and prevent HIV infections. Top Antivir Med. 2014 May; 22(2):579-93. Buchbinder SP, Liu AY. PMID: 24901884; PMCID: PMC6148913.
      View in: PubMed   Mentions:
    91. Intentions to prescribe preexposure prophylaxis are associated with self-efficacy and normative beliefs. Clin Infect Dis. 2014 Jun; 58(12):1786-7. Sachdev DD, Stojanovski K, Liu AY, Buchbinder SP, Macalino GE. PMID: 24729556; PMCID: PMC4110450.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    92. Immunology. Immune activation with HIV vaccines. Science. 2014 Apr 04; 344(6179):49-51. Fauci AS, Marovich MA, Dieffenbach CW, Hunter E, Buchbinder SP. PMID: 24700849; PMCID: PMC4414116.
      View in: PubMed   Mentions:
    93. Over-the-counter human immunodeficiency virus self-test kits: time to explore their use for men who have sex with men in Brazil. Braz J Infect Dis. 2014 May-Jun; 18(3):239-44. Lippman SA, Veloso VG, Buchbinder S, Fernandes NM, Terto V, Sullivan PS, Grinsztejn B. PMID: 24704388; PMCID: PMC9427457.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    94. HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial. Lancet Infect Dis. 2014 Jun; 14(6):468-75. Buchbinder SP, Glidden DV, Liu AY, McMahan V, Guanira JV, Mayer KH, Goicochea P, Grant RM. PMID: 24613084; PMCID: PMC4133171.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansCTClinical Trials
    95. LILRB2 interaction with HLA class I correlates with control of HIV-1 infection. PLoS Genet. 2014 Mar; 10(3):e1004196. Bashirova AA, Martin-Gayo E, Jones DC, Qi Y, Apps R, Gao X, Burke PS, Taylor CJ, Rogich J, Wolinsky S, Bream JH, Duggal P, Hussain S, Martinson J, Weintrob A, Kirk GD, Fellay J, Buchbinder SP, Goedert JJ, Deeks SG, Pereyra F, Trowsdale J, Lichterfeld M, Telenti A, Walker BD, Allen RL, Carrington M, Yu XG. PMID: 24603468; PMCID: PMC3945438.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    96. Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med. 2014 Mar; 11(3):e1001613. Liu A, Cohen S, Follansbee S, Cohan D, Weber S, Sachdev D, Buchbinder S. PMID: 24595035; PMCID: PMC3942317.
      View in: PubMed   Mentions: 147     Fields:    Translation:Humans
    97. Helping our patients take HIV pre-exposure prophylaxis (PrEP): a systematic review of adherence interventions. HIV Med. 2014 Aug; 15(7):385-95. Marcus JL, Buisker T, Horvath T, Amico KR, Fuchs JD, Buchbinder SP, Grant RM, Liu AY. PMID: 24580813; PMCID: PMC4107052.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansPHPublic Health
    98. Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP). PLoS One. 2014; 9(1):e83736. Liu AY, Yang Q, Huang Y, Bacchetti P, Anderson PL, Jin C, Goggin K, Stojanovski K, Grant R, Buchbinder SP, Greenblatt RM, Gandhi M. PMID: 24421901; PMCID: PMC3885443.
      View in: PubMed   Mentions: 102     Fields:    Translation:HumansCTClinical Trials
    99. Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles. J Infect Dis. 2014 Jul 01; 210(1):99-110. Goepfert PA, Elizaga ML, Seaton K, Tomaras GD, Montefiori DC, Sato A, Hural J, DeRosa SC, Kalams SA, McElrath MJ, Keefer MC, Baden LR, Lama JR, Sanchez J, Mulligan MJ, Buchbinder SP, Hammer SM, Koblin BA, Pensiero M, Butler C, Moss B, Robinson HL. PMID: 24403557; PMCID: PMC4072895.
      View in: PubMed   Mentions:
    100. Age, race/ethnicity, and behavioral risk factors associated with per contact risk of HIV infection among men who have sex with men in the United States. J Acquir Immune Defic Syndr. 2014 Jan 01; 65(1):115-21. Scott HM, Vittinghoff E, Irvin R, Sachdev D, Liu A, Gurwith M, Buchbinder SP. PMID: 24419067; PMCID: PMC3894586.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    101. Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States. PLoS One. 2013; 8(12):e82772. Konikoff J, Brookmeyer R, Longosz AF, Cousins MM, Celum C, Buchbinder SP, Seage GR, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Justman JE, Hodder SL, Quinn TC, Eshleman SH, Laeyendecker O. PMID: 24386116; PMCID: PMC3873916.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    102. No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis. PLoS One. 2013; 8(12):e81997. Marcus JL, Glidden DV, Mayer KH, Liu AY, Buchbinder SP, Amico KR, McMahan V, Kallas EG, Montoya-Herrera O, Pilotto J, Grant RM. PMID: 24367497; PMCID: PMC3867330.
      View in: PubMed   Mentions: 123     Fields:    Translation:Humans
    103. HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithm. J Clin Microbiol. 2014 Jan; 52(1):115-21. Cousins MM, Konikoff J, Laeyendecker O, Celum C, Buchbinder SP, Seage GR, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Wheeler D, Justman JE, Hodder SL, Quinn TC, Brookmeyer R, Eshleman SH. PMID: 24153134; PMCID: PMC3911463.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    104. The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participants. Int J STD AIDS. 2014 Apr; 25(5):332-40. Volk JE, Hessol NA, Gray GE, Kublin JG, Churchyard GJ, Mlisana K, Nchabeleng M, Buchbinder SP, Bekker LG. PMID: 24104693; PMCID: PMC3968181.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    105. Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine. N Engl J Med. 2013 Nov 28; 369(22):2083-92. Hammer SM, Sobieszczyk ME, Janes H, Karuna ST, Mulligan MJ, Grove D, Koblin BA, Buchbinder SP, Keefer MC, Tomaras GD, Frahm N, Hural J, Anude C, Graham BS, Enama ME, Adams E, DeJesus E, Novak RM, Frank I, Bentley C, Ramirez S, Fu R, Koup RA, Mascola JR, Nabel GJ, Montefiori DC, Kublin J, McElrath MJ, Corey L, Gilbert PB, HVTN 505 Study Team. PMID: 24099601; PMCID: PMC4030634.
      View in: PubMed   Mentions:
    106. Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States. J Acquir Immune Defic Syndr. 2013 Sep 01; 64(1):79-86. Grohskopf LA, Chillag KL, Gvetadze R, Liu AY, Thompson M, Mayer KH, Collins BM, Pathak SR, O'hara B, Ackers ML, Rose CE, Grant RM, Paxton LA, Buchbinder SP. PMID: 23466649.
      View in: PubMed   Mentions: 91     Fields:    Translation:Humans
    107. Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United States. J Acquir Immune Defic Syndr. 2013 Sep 01; 64(1):87-94. Liu AY, Vittinghoff E, Chillag K, Mayer K, Thompson M, Grohskopf L, Colfax G, Pathak S, Gvetadze R, O'hara B, Collins B, Ackers M, Paxton L, Buchbinder SP. PMID: 23481668; PMCID: PMC3904758.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCTClinical Trials
    108. CROI 2013: New tools to understand transmission dynamics and prevent HIV infections. Top Antivir Med. 2013 Apr-May; 21(2):47-61. Buchbinder SP, Liu AY. PMID: 23681960; PMCID: PMC6148871.
      View in: PubMed   Mentions:
    109. What drives the US and Peruvian HIV epidemics in men who have sex with men (MSM)? PLoS One. 2012; 7(11):e50522. Goodreau SM, Carnegie NB, Vittinghoff E, Lama JR, Sanchez J, Grinsztejn B, Koblin BA, Mayer KH, Buchbinder SP. PMID: 23209768; PMCID: PMC3510067.
      View in: PubMed   Mentions: 221     Fields:    Translation:Humans
    110. HIV incidence determination in the United States: a multiassay approach. J Infect Dis. 2013 Jan 15; 207(2):232-9. Laeyendecker O, Brookmeyer R, Cousins MM, Mullis CE, Konikoff J, Donnell D, Celum C, Buchbinder SP, Seage GR, Kirk GD, Mehta SH, Astemborski J, Jacobson LP, Margolick JB, Brown J, Quinn TC, Eshleman SH. PMID: 23129760; PMCID: PMC3532826.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCells
    111. Seroadaptive practices: association with HIV acquisition among HIV-negative men who have sex with men. PLoS One. 2012; 7(10):e45718. Vallabhaneni S, Li X, Vittinghoff E, Donnell D, Pilcher CD, Buchbinder SP. PMID: 23056215; PMCID: PMC3463589.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    112. Sexual frequency and planning among at-risk men who have sex with men in the United States: implications for event-based intermittent pre-exposure prophylaxis. J Acquir Immune Defic Syndr. 2012 Sep 01; 61(1):112-5. Volk JE, Liu A, Vittinghoff E, Irvin R, Kroboth E, Krakower D, Mimiaga MJ, Mayer KH, Sullivan PS, Buchbinder SP. PMID: 22592590; PMCID: PMC3427423.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    113. Sexual risk behaviors, circumcision status, and preexisting immunity to adenovirus type 5 among men who have sex with men participating in a randomized HIV-1 vaccine efficacy trial: step study. J Acquir Immune Defic Syndr. 2012 Aug 01; 60(4):405-13. Koblin BA, Mayer KH, Noonan E, Wang CY, Marmor M, Sanchez J, Brown SJ, Robertson MN, Buchbinder SP. PMID: 22421748; PMCID: PMC3392543.
      View in: PubMed   Mentions:
    114. Antiretroviral use for prevention and other factors affecting the course of the HIV-1 epidemic. Top Antivir Med. 2012 Jun-Jul; 20(2):32-40. Buchbinder SP. PMID: 22710905; PMCID: PMC6148860.
      View in: PubMed   Mentions:
    115. Preexisting adenovirus seropositivity is not associated with increased HIV-1 acquisition in three HIV-1 vaccine efficacy trials. J Infect Dis. 2012 Jun 15; 205(12):1806-10. Stephenson KE, Hural J, Buchbinder SP, Sinangil F, Barouch DH. PMID: 22492863; PMCID: PMC3415893.
      View in: PubMed   Mentions:
    116. Decreased pre-existing Ad5 capsid and Ad35 neutralizing antibodies increase HIV-1 infection risk in the Step trial independent of vaccination. PLoS One. 2012; 7(4):e33969. Cheng C, Wang L, Wang L, Gall JG, Nason M, Schwartz RM, McElrath MJ, DeRosa SC, Hural J, Corey L, Buchbinder SP, Nabel GJ. PMID: 22496775; PMCID: PMC3319553.
      View in: PubMed   Mentions:
    117. Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine. J Clin Invest. 2012 Jan; 122(1):359-67. Frahm N, DeCamp AC, Friedrich DP, Carter DK, Defawe OD, Kublin JG, Casimiro DR, Duerr A, Robertson MN, Buchbinder SP, Huang Y, Spies GA, De Rosa SC, McElrath MJ. PMID: 22201684; PMCID: PMC3248307.
      View in: PubMed   Mentions:
    118. Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection. PLoS One. 2011; 6(11):e27211. Cousins MM, Laeyendecker O, Beauchamp G, Brookmeyer R, Towler WI, Hudelson SE, Khaki L, Koblin B, Chesney M, Moore RD, Kelen GD, Coates T, Celum C, Buchbinder SP, Seage GR, Quinn TC, Donnell D, Eshleman SH. PMID: 22073290; PMCID: PMC3206918.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    119. Role of exonic variation in chemokine receptor genes on AIDS: CCRL2 F167Y association with pneumocystis pneumonia. PLoS Genet. 2011 Oct; 7(10):e1002328. An P, Li R, Wang JM, Yoshimura T, Takahashi M, Samudralal R, O'Brien SJ, Phair J, Goedert JJ, Kirk GD, Troyer JL, Sezgin E, Buchbinder SP, Donfield S, Nelson GW, Winkler CA. PMID: 22046140; PMCID: PMC3203199.
      View in: PubMed   Mentions:
    120. A Sequential Phase 2b Trial Design for Evaluating Vaccine Efficacy and Immune Correlates for Multiple HIV Vaccine Regimens. Stat Commun Infect Dis. 2011 Oct; 3(1). Gilbert PB, Grove D, Gabriel E, Huang Y, Gray G, Hammer SM, Buchbinder SP, Kublin J, Corey L, Self SG. PMID: 23181167; PMCID: PMC3502884.
      View in: PubMed   Mentions:
    121. Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco. PLoS One. 2011; 6(8):e23688. Liu AY, Vittinghoff E, Sellmeyer DE, Irvin R, Mulligan K, Mayer K, Thompson M, Grant R, Pathak S, O'Hara B, Gvetadze R, Chillag K, Grohskopf L, Buchbinder SP. PMID: 21897852; PMCID: PMC3163584.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    122. Impact of herpes simplex virus type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the Step study). J Acquir Immune Defic Syndr. 2011 Jul 01; 57(3):238-44. Barnabas RV, Wasserheit JN, Huang Y, Janes H, Morrow R, Fuchs J, Mark KE, Casapia M, Mehrotra DV, Buchbinder SP, Corey L, NIAID HIV Vaccine Trials Network. PMID: 21860356; PMCID: PMC3446850.
      View in: PubMed   Mentions:
    123. International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations. Vaccine. 2011 Jul 18; 29(32):5203-9. Barouch DH, Kik SV, Weverling GJ, Dilan R, King SL, Maxfield LF, Clark S, Ng'ang'a D, Brandariz KL, Abbink P, Sinangil F, de Bruyn G, Gray GE, Roux S, Bekker LG, Dilraj A, Kibuuka H, Robb ML, Michael NL, Anzala O, Amornkul PN, Gilmour J, Hural J, Buchbinder SP, Seaman MS, Dolin R, Baden LR, Carville A, Mansfield KG, Pau MG, Goudsmit J. PMID: 21619905; PMCID: PMC3138857.
      View in: PubMed   Mentions:
    124. HIV epidemiology and breakthroughs in prevention 30 years into the AIDS epidemic. Top Antivir Med. 2011 May-Jun; 19(2):38-46. Buchbinder SP. PMID: 21868821; PMCID: PMC6148950.
      View in: PubMed   Mentions:
    125. Pre-exposure prophylaxis and the promise of combination prevention approaches. AIDS Behav. 2011 Apr; 15 Suppl 1:S72-9. Buchbinder SP, Liu A. PMID: 21331801; PMCID: PMC3064892.
      View in: PubMed   Mentions:
    126. Absence of reproducibly detectable low-level HIV viremia in highly exposed seronegative men and women. AIDS. 2011 Mar 13; 25(5):619-23. Delwart E, Bernardin F, Lee TH, Winkelman V, Liu C, Sheppard H, Liu A, Greenblatt R, Anastos K, DeHovitz J, Nowicki M, Cohen M, Golub ET, Barbour J, Buchbinder S, Busch MP, NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI). PMID: 21297421; PMCID: PMC3458706.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    127. Male circumcision and risk of HIV acquisition among MSM. AIDS. 2011 Feb 20; 25(4):519-23. Sánchez J, Sal Y Rosas VG, Hughes JP, Baeten JM, Fuchs J, Buchbinder SP, Koblin BA, Casapia M, Ortiz A, Celum C. PMID: 21099672; PMCID: PMC3120051.
      View in: PubMed   Mentions:
    128. Genetic associations of variants in genes encoding HIV-dependency factors required for HIV-1 infection. J Infect Dis. 2010 Dec 15; 202(12):1836-45. Chinn LW, Tang M, Kessing BD, Lautenberger JA, Troyer JL, Malasky MJ, McIntosh C, Kirk GD, Wolinsky SM, Buchbinder SP, Gomperts ED, Goedert JJ, O'Brien SJ. PMID: 21083371; PMCID: PMC3107555.
      View in: PubMed   Mentions:
    129. Lessons drawn from recent HIV vaccine efficacy trials. J Acquir Immune Defic Syndr. 2010 Dec; 55 Suppl 2:S128-31. Fuchs JD, Sobieszczyk ME, Hammer SM, Buchbinder SP. PMID: 21406982; PMCID: PMC3079543.
      View in: PubMed   Mentions:
    130. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010 Dec 30; 363(27):2587-99. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapía M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernández T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker LG, Mayer KH, Kallás EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell JJ, Zheng JH, Lee J, Rooney JF, Jaffe HS, Martinez AI, Burns DN, Glidden DV, iPrEx Study Team. PMID: 21091279; PMCID: PMC3079639.
      View in: PubMed   Mentions: 2525     Fields:    Translation:HumansCells
    131. Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. PLoS One. 2010 Sep 21; 5(9):e12862. Hendrickson SL, Lautenberger JA, Chinn LW, Malasky M, Sezgin E, Kingsley LA, Goedert JJ, Kirk GD, Gomperts ED, Buchbinder SP, Troyer JL, O'Brien SJ. PMID: 20877624; PMCID: PMC2943476.
      View in: PubMed   Mentions:
    132. Early versus deferred antiretroviral therapy for HIV. N Engl J Med. 2009 Aug 20; 361(8):822; author reply 823-4. Buchbinder SP, Jain V. PMID: 19692695.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    133. Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men. AIDS. 2009 Jun 01; 23(9):1135-42. Chin-Hong PV, Husnik M, Cranston RD, Colfax G, Buchbinder S, Da Costa M, Darragh T, Jones D, Judson F, Koblin B, Mayer KH, Palefsky JM. PMID: 19390418; PMCID: PMC4577294.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansCells
    134. The epidemiology of new HIV infections and interventions to limit HIV transmission. Top HIV Med. 2009 Apr-May; 17(2):37-43. Buchbinder S. PMID: 19401606.
      View in: PubMed   Mentions:
    135. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet. 2008 Nov 29; 372(9653):1881-1893. Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, Gilbert PB, Lama JR, Marmor M, Del Rio C, McElrath MJ, Casimiro DR, Gottesdiener KM, Chodakewitz JA, Corey L, Robertson MN, Step Study Protocol Team. PMID: 19012954; PMCID: PMC2721012.
      View in: PubMed   Mentions:
    136. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet. 2008 Nov 29; 372(9653):1894-1905. McElrath MJ, De Rosa SC, Moodie Z, Dubey S, Kierstead L, Janes H, Defawe OD, Carter DK, Hural J, Akondy R, Buchbinder SP, Robertson MN, Mehrotra DV, Self SG, Corey L, Shiver JW, Casimiro DR, Step Study Protocol Team. PMID: 19012957; PMCID: PMC2774110.
      View in: PubMed   Mentions:
    137. Potentially exposed but uninfected individuals produce cytotoxic and polyfunctional human immunodeficiency virus type 1-specific CD8(+) T-cell responses which can be defined to the epitope level. Clin Vaccine Immunol. 2008 Nov; 15(11):1745-8. Erickson AL, Willberg CB, McMahan V, Liu A, Buchbinder SP, Grohskopf LA, Grant RM, Nixon DF. PMID: 18815234; PMCID: PMC2583520.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    138. Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. HIV testing and prevention strategies. Top HIV Med. 2008 Apr-May; 16(1):9-14. Buchbinder S. PMID: 18441378.
      View in: PubMed   Mentions:
    139. Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men. J Acquir Immune Defic Syndr. 2008 Feb 01; 47(2):241-7. Liu AY, Kittredge PV, Vittinghoff E, Raymond HF, Ahrens K, Matheson T, Hecht J, Klausner JD, Buchbinder SP. PMID: 18340656.
      View in: PubMed   Mentions: 96     Fields:    Translation:Humans
    140. Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial. J Acquir Immune Defic Syndr. 2007 Feb 01; 44(2):203-12. Russell ND, Graham BS, Keefer MC, McElrath MJ, Self SG, Weinhold KJ, Montefiori DC, Ferrari G, Horton H, Tomaras GD, Gurunathan S, Baglyos L, Frey SE, Mulligan MJ, Harro CD, Buchbinder SP, Baden LR, Blattner WA, Koblin BA, Corey L, National Institute of Allergy and Infectious Diseases HIV Vaccine Trials Network. PMID: 17106277; PMCID: PMC2362395.
      View in: PubMed   Mentions:
    141. Prevalence and incidence of pharyngeal gonorrhea in a longitudinal sample of men who have sex with men: the EXPLORE study. Clin Infect Dis. 2006 Nov 15; 43(10):1284-9. Morris SR, Klausner JD, Buchbinder SP, Wheeler SL, Koblin B, Coates T, Chesney M, Colfax GN. PMID: 17051493.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    142. Partner-specific sexual behavioral differences between phase 3 HIV vaccine efficacy trial participants and controls: Project VISION. J Acquir Immune Defic Syndr. 2006 Oct 01; 43(2):234-8. Whittington WL, Morris M, Buchbinder SP, McKirnan DJ, Mayer KH, Para MF, Bartholow BN, Celum CL. PMID: 16951646.
      View in: PubMed   Mentions:
    143. Preexposure prophylaxis for HIV: unproven promise and potential pitfalls. JAMA. 2006 Aug 16; 296(7):863-5. Liu AY, Grant RM, Buchbinder SP. PMID: 16905792.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    144. AIDS. Promote HIV chemoprophylaxis research, don't prevent it. Science. 2005 Sep 30; 309(5744):2170-1. Grant RM, Buchbinder S, Cates W, Clarke E, Coates T, Cohen MS, Delaney M, Flores G, Goicochea P, Gonsalves G, Harrington M, Lama JR, MacQueen KM, Moore JP, Peterson L, Sanchez J, Thompson M, Wainberg MA. PMID: 16195446.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    145. New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid. Clin Chem. 2005 Aug; 51(8):1480-6. Kratzsch J, Fiedler GM, Leichtle A, Brügel M, Buchbinder S, Otto L, Sabri O, Matthes G, Thiery J. PMID: 15961550.
      View in: PubMed   Mentions:
    146. Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study. J Natl Cancer Inst. 2005 Jun 15; 97(12):896-905. Chin-Hong PV, Vittinghoff E, Cranston RD, Browne L, Buchbinder S, Colfax G, Da Costa M, Darragh T, Benet DJ, Judson F, Koblin B, Mayer KH, Palefsky JM. PMID: 15956651.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCells
    147. Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States. J Acquir Immune Defic Syndr. 2005 May 01; 39(1):82-9. Buchbinder SP, Vittinghoff E, Heagerty PJ, Celum CL, Seage GR, Judson FN, McKirnan D, Mayer KH, Koblin BA. PMID: 15851918.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    148. Age-Specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study. J Infect Dis. 2004 Dec 15; 190(12):2070-6. Chin-Hong PV, Vittinghoff E, Cranston RD, Buchbinder S, Cohen D, Colfax G, Da Costa M, Darragh T, Hess E, Judson F, Koblin B, Madison M, Palefsky JM. PMID: 15551204.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansCells
    149. Alcohol use and high-risk sexual behavior among men who have sex with men: the effects of consumption level and partner type. Health Psychol. 2004 Sep; 23(5):525-32. Vanable PA, McKirnan DJ, Buchbinder SP, Bartholow BN, Douglas JM, Judson FN, MacQueen KM. PMID: 15367072.
      View in: PubMed   Mentions:
    150. Beliefs about HIV reinfection (superinfection) and sexual behavior among a diverse sample of HIV-positive men who have sex with men. J Acquir Immune Defic Syndr. 2004 Aug 01; 36(4):990-2. Colfax GN, Guzman R, Wheeler S, Mansergh G, Marks G, Rader M, Buchbinder SP. PMID: 15220710.
      View in: PubMed   Mentions:
    151. Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160. J Infect Dis. 2004 Sep 01; 190(5):903-7. Lee D, Graham BS, Chiu YL, Gilbert PB, McElrath MJ, Belshe RB, Buchbinder SP, Sheppard HW, Koblin BA, Mayer KH, Keefer MC, Mulligan MJ, Celum CL. PMID: 15295694.
      View in: PubMed   Mentions:
    152. Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation. J Acquir Immune Defic Syndr. 2004 May 01; 36(1):604-12. Buchbinder SP, Metch B, Holte SE, Scheer S, Coletti A, Vittinghoff E. PMID: 15097304.
      View in: PubMed   Mentions: 79     Fields:    Translation:Humans
    153. Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection. AIDS. 2003 Feb 14; 17(3):377-87. Mulherin SA, O'Brien TR, Ioannidis JP, Goedert JJ, Buchbinder SP, Coutinho RA, Jamieson BD, Meyer L, Michael NL, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Theodorou ID, Vlahov D, Rosenberg PS, International Meta-Analysis of HIV Host Genetics. PMID: 12556692.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    154. Herpes simplex virus type 2 infection as a risk factor for human immunodeficiency virus acquisition in men who have sex with men. J Infect Dis. 2003 Jan 01; 187(1):19-25. Renzi C, Douglas JM, Foster M, Critchlow CW, Ashley-Morrow R, Buchbinder SP, Koblin BA, McKirnan DJ, Mayer KH, Celum CL. PMID: 12508142.
      View in: PubMed   Mentions:
    155. Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion. AIDS. 2002 Jul 26; 16(11):1529-35. Colfax GN, Buchbinder SP, Cornelisse PG, Vittinghoff E, Mayer K, Celum C. PMID: 12131191.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    156. HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion. J Acquir Immune Defic Syndr. 2002 Mar 01; 29(3):307-13. Sheppard HW, Celum C, Michael NL, O'Brien S, Dean M, Carrington M, Dondero D, Buchbinder SP. PMID: 11873082.
      View in: PubMed   Mentions:
    157. Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic. JAMA. 2002 Jan 09; 287(2):221-5. Osmond DH, Buchbinder S, Cheng A, Graves A, Vittinghoff E, Cossen CK, Forghani B, Martin JN. PMID: 11779265.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCellsPHPublic Health
    158. Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med. 2001 Nov 06; 135(9):782-95. Ioannidis JP, Rosenberg PS, Goedert JJ, Ashton LJ, Benfield TL, Buchbinder SP, Coutinho RA, Eugen-Olsen J, Gallart T, Katzenstein TL, Kostrikis LG, Kuipers H, Louie LG, Mallal SA, Margolick JB, Martinez OP, Meyer L, Michael NL, Operskalski E, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Stewart GJ, Theodorou ID, Ullum H, Vicenzi E, Vlahov D, Wilkinson D, Workman C, Zagury JF, O'Brien TR, International Meta-Analysis of HIV Host Genetics. PMID: 11694103.
      View in: PubMed   Mentions: 102     Fields:    Translation:HumansCells
    159. Cofactors for HIV disease progression in a cohort of homosexual and bisexual men. J Acquir Immune Defic Syndr. 2001 Jul 01; 27(3):308-14. Vittinghoff E, Hessol NA, Bacchetti P, Fusaro RE, Holmberg SD, Buchbinder SP. PMID: 11464153.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    160. Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA alleles. J Virol. 2001 Jul; 75(14):6279-91. Day CL, Shea AK, Altfeld MA, Olson DP, Buchbinder SP, Hecht FM, Rosenberg ES, Walker BD, Kalams SA. PMID: 11413294; PMCID: PMC114350.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    161. Persistence of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte clones in a subject with rapid disease progression. J Virol. 2001 May; 75(10):4907-11. Islam SA, Hay CM, Hartman KE, He S, Shea AK, Trocha AK, Dynan MJ, Reshamwala N, Buchbinder SP, Basgoz NO, Kalams SA. PMID: 11312363; PMCID: PMC114246.
      View in: PubMed   Mentions:
    162. Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. Am J Epidemiol. 2001 Apr 01; 153(7):619-27. Seage GR, Holte SE, Metzger D, Koblin BA, Gross M, Celum C, Marmor M, Woody G, Mayer KH, Stevens C, Judson FN, McKirnan D, Sheon A, Self S, Buchbinder SP. PMID: 11282787.
      View in: PubMed   Mentions:
    163. Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load. J Infect Dis. 2001 Jan 01; 183(1):23-35. Celum CL, Buchbinder SP, Donnell D, Douglas JM, Mayer K, Koblin B, Marmor M, Bozeman S, Grant RM, Flores J, Sheppard HW. PMID: 11106536.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    164. Feasibility of chemoprophylaxis studies in high risk HIV-seronegative populations. AIDS Educ Prev. 2000 Feb; 12(1):71-8. Gross M, Holte S, Seage GR, Buchbinder SP, Metzger DS, Mayer KH. PMID: 10749387.
      View in: PubMed   Mentions:
    165. Long-term survival after infection with human immunodeficiency virus type 1 (HIV-1) among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1995. Am J Epidemiol. 1999 Nov 15; 150(10):1026-30. Koblin BA, van Benthem BH, Buchbinder SP, Ren L, Vittinghoff E, Stevens CE, Coutinho RA, van Griensven GJ. PMID: 10568617.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    166. Use of reality "female condoms" for anal sex by US men who have sex with men. HIVNET Vaccine Preparedness Study Protocol Team. Am J Public Health. 1999 Nov; 89(11):1739-41. Gross M, Buchbinder SP, Holte S, Celum CL, Koblin BA, Douglas JM. PMID: 10553399; PMCID: PMC1508971.
      View in: PubMed   Mentions:
    167. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection. J Virol. 1999 Aug; 73(8):6715-20. Kalams SA, Buchbinder SP, Rosenberg ES, Billingsley JM, Colbert DS, Jones NG, Shea AK, Trocha AK, Walker BD. PMID: 10400769; PMCID: PMC112756.
      View in: PubMed   Mentions: 116     Fields:    Translation:HumansCells
    168. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol. 1999 Aug 01; 150(3):306-11. Vittinghoff E, Douglas J, Judson F, McKirnan D, MacQueen K, Buchbinder SP. PMID: 10430236.
      View in: PubMed   Mentions: 199     Fields:    Translation:HumansPHPublic Health
    169. Combination antiretroviral therapy and incidence of AIDS-related malignancies. J Acquir Immune Defic Syndr. 1999 Aug 01; 21 Suppl 1:S23-6. Buchbinder SP, Holmberg SD, Scheer S, Colfax G, O'Malley P, Vittinghoff E. PMID: 10430214.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    170. Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors. J Infect Dis. 1999 May; 179(5):1264-7. Bradney AP, Scheer S, Crawford JM, Buchbinder SP, Montefiori DC. PMID: 10191234.
      View in: PubMed   Mentions:
    171. Correlates of condom failure in a sexually active cohort of men who have sex with men. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 15; 20(5):495-501. Stone E, Heagerty P, Vittinghoff E, Douglas JM, Koblin BA, Mayer KH, Celum CL, Gross M, Woody GE, Marmor M, Seage GR, Buchbinder SP. PMID: 10225233.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    172. Combination antiretroviral therapy and recent declines in AIDS incidence and mortality. J Infect Dis. 1999 Mar; 179(3):717-20. Vittinghoff E, Scheer S, O'Malley P, Colfax G, Holmberg SD, Buchbinder SP. PMID: 9952385.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    173. Diminished spontaneous apoptosis in lymphocytes from human immunodeficiency virus-infected long-term nonprogressors. J Infect Dis. 1998 Sep; 178(3):669-79. Liegler TJ, Yonemoto W, Elbeik T, Vittinghoff E, Buchbinder SP, Greene WC. PMID: 9728534.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    174. Rectal microbicides for U.S. gay men. Are clinical trials needed? Are they feasible? HIVNET Vaccine Preparedness Study Protocol Team. Sex Transm Dis. 1998 Jul; 25(6):296-302. Gross M, Buchbinder SP, Celum C, Heagerty P, Seage GR. PMID: 9662763.
      View in: PubMed   Mentions:
    175. Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection. J Clin Invest. 1998 Jun 01; 101(11):2559-66. Brander C, Hartman KE, Trocha AK, Jones NG, Johnson RP, Korber B, Wentworth P, Buchbinder SP, Wolinsky S, Walker BD, Kalams SA. PMID: 9616227; PMCID: PMC508845.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    176. Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: effects of viral variation on cytotoxic T-lymphocyte recognition. J Virol. 1997 Feb; 71(2):1256-64. Wilson CC, Kalams SA, Wilkes BM, Ruhl DJ, Gao F, Hahn BH, Hanson IC, Luzuriaga K, Wolinsky S, Koup R, Buchbinder SP, Johnson RP, Walker BD. PMID: 8995649; PMCID: PMC191180.
      View in: PubMed   Mentions:
    177. Insurance type and satisfaction with medical care among HIV-infected men. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jan 01; 14(1):35-43. Katz MH, Marx R, Douglas JM, Bolan GA, Park MS, Gurley RJ, Buchbinder SP. PMID: 8989209.
      View in: PubMed   Mentions:
    178. Increased incidence of cancer among homosexual men, New York City and San Francisco, 1978-1990. Am J Epidemiol. 1996 Nov 15; 144(10):916-23. Koblin BA, Hessol NA, Zauber AG, Taylor PE, Buchbinder SP, Katz MH, Stevens CE. PMID: 8916502.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    179. Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: risk behavior, seroincidence, and willingness to participate. J Infect Dis. 1996 Nov; 174(5):954-61. Buchbinder SP, Douglas JM, McKirnan DJ, Judson FN, Katz MH, MacQueen KM. PMID: 8896495.
      View in: PubMed   Mentions:
    180. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science. 1996 Sep 27; 273(5283):1856-62. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R, O'Brien SJ. PMID: 8791590.
      View in: PubMed   Mentions: 707     Fields:    Translation:HumansCells
    181. The association between cigarette smoking and selected HIV-related medical conditions. AIDS. 1996 Sep; 10(10):1121-6. Conley LJ, Bush TJ, Buchbinder SP, Penley KA, Judson FN, Holmberg SD. PMID: 8874629.
      View in: PubMed   Mentions:
    182. Depression and use of mental health services among HIV-infected men. AIDS Care. 1996 Aug; 8(4):433-42. Katz MH, Douglas JM, Bolan GA, Marx R, Sweat M, Park MS, Buchbinder SP. PMID: 8863914.
      View in: PubMed   Mentions:
    183. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res Hum Retroviruses. 1996 May 01; 12(7):585-92. Harrer T, Harrer E, Kalams SA, Elbeik T, Staprans SI, Feinberg MB, Cao Y, Ho DD, Yilma T, Caliendo AM, Johnson RP, Buchbinder SP, Walker BD. PMID: 8743084.
      View in: PubMed   Mentions: 91     Fields:    Translation:HumansCells
    184. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J Immunol. 1996 Apr 01; 156(7):2616-23. Harrer T, Harrer E, Kalams SA, Barbosa P, Trocha A, Johnson RP, Elbeik T, Feinberg MB, Buchbinder SP, Walker BD. PMID: 8786327.
      View in: PubMed   Mentions:
    185. T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant. J Exp Med. 1996 Apr 01; 183(4):1669-79. Kalams SA, Johnson RP, Dynan MJ, Hartman KE, Harrer T, Harrer E, Trocha AK, Blattner WA, Buchbinder SP, Walker BD. PMID: 8666925; PMCID: PMC2192525.
      View in: PubMed   Mentions:
    186. Required HIV antibody testing, social risk, and HIV-vaccine efficacy trials. AIDS Public Policy J. 1996; 11(2):104-12. MacQueen KM, Buchbinder SP, Douglas JM, Judson FN, McKirnan DJ, Bartholow BN. PMID: 10915243.
      View in: PubMed   Mentions:
    187. The spectrum of medical conditions and symptoms before acquired immunodeficiency syndrome in homosexual and bisexual men infected with the human immunodeficiency virus. Am J Epidemiol. 1995 Mar 01; 141(5):395-404; discussion 405-6. Holmberg SD, Buchbinder SP, Conley LJ, Wong LC, Katz MH, Penley KA, Hershow RC, Judson FN. PMID: 7879784.
      View in: PubMed   Mentions:
    188. Health insurance and use of medical services by men infected with HIV. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jan 01; 8(1):58-63. Katz MH, Chang SW, Buchbinder SP, Hessol NA, O'Malley P, Doll LS. PMID: 8548347.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    189. Hepatitis C virus infection in sexually active homosexual men. J Infect. 1994 Nov; 29(3):263-9. Buchbinder SP, Katz MH, Hessol NA, Liu J, O'Malley PM, Alter MJ. PMID: 7884219.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    190. Long-term HIV-1 infection without immunologic progression. AIDS. 1994 Aug; 8(8):1123-8. Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD. PMID: 7986410.
      View in: PubMed   Mentions: 89     Fields:    Translation:HumansCellsCTClinical Trials
    191. Temporal trends of opportunistic infections and malignancies in homosexual men with AIDS. J Infect Dis. 1994 Jul; 170(1):198-202. Katz MH, Hessol NA, Buchbinder SP, Hirozawa A, O'Malley P, Holmberg SD. PMID: 8014498.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    192. Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991. Am J Epidemiol. 1994 Jun 01; 139(11):1077-87. Hessol NA, Koblin BA, van Griensven GJ, Bacchetti P, Liu JY, Stevens CE, Coutinho RA, Buchbinder SP, Katz MH. PMID: 8192140.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    193. Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts. AIDS. 1994 Jan; 8(1):73-9. Lifson AR, Hilton JF, Westenhouse JL, Canchola AJ, Samuel MC, Katz MH, Buchbinder SP, Hessol NA, Osmond DH, Shiboski S, et al. PMID: 8011239.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    194. Use of therapeutic and prophylactic drugs for AIDS by homosexual and bisexual men in three US cities. AIDS. 1993 May; 7(5):699-704. Holmberg SD, Conley LJ, Buchbinder SP, Judson FN, Bush TJ, Katz MH, Penley KA, Hershow RC. PMID: 8318177.
      View in: PubMed   Mentions:
    195. Epidemiology of human immunodeficiency virus type 1 infection among homosexual men participating in hepatitis B vaccine trials in Amsterdam, New York City, and San Francisco, 1978-1990. Am J Epidemiol. 1993 Apr 15; 137(8):909-15. van Griensven GJ, Hessol NA, Koblin BA, Byers RH, O'Malley PM, Albercht-van Lent N, Buchbinder SP, Taylor PE, Stevens CE, Coutinho RA. PMID: 8484382.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    196. Use of Bayes theorem to estimate the impact of the proposed CD4-based expansion of the AIDS case definition. J Acquir Immune Defic Syndr (1988). 1993 Mar; 6(3):295-7. Katz MH, Hessol NA, Buchbinder SP, Mebane WR, O'Malley P, Lemp GF, Holmberg SD. PMID: 8383734.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    197. Herpes zoster and human immunodeficiency virus infection. J Infect Dis. 1992 Nov; 166(5):1153-6. Buchbinder SP, Katz MH, Hessol NA, Liu JY, O'Malley PM, Underwood R, Holmberg SD. PMID: 1308664.
      View in: PubMed   Mentions: 79     Fields:    Translation:Humans
    198. Increased incidence of Hodgkin disease in homosexual men with HIV infection. Ann Intern Med. 1992 Aug 15; 117(4):309-11. Hessol NA, Katz MH, Liu JY, Buchbinder SP, Rubino CJ, Holmberg SD. PMID: 1637026.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    199. Serum beta 2-microglobulin and prediction of progression to AIDS in HIV infection. Lancet. 1992 Jun 13; 339(8807):1436-40. Lifson AR, Hessol NA, Buchbinder SP, O'Malley PM, Barnhart L, Segal M, Katz MH, Holmberg SD. PMID: 1351128.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    200. Impact of HIV infection on mortality and accuracy of AIDS reporting on death certificates. Am J Public Health. 1992 Apr; 82(4):561-4. Hessol NA, Buchbinder SP, Colbert D, Scheer S, Underwood R, Barnhart JL, O'Malley PM, Doll LS, Lifson AR. PMID: 1546772; PMCID: PMC1694104.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCellsPHPublic Health
    201. Predictors of HIV disease progression in the era of prophylactic therapies. AIDS Clin Rev. 1992; 25-40. Hessol NA, Buchbinder SP. PMID: 1606059.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    202. Progression to AIDS in HIV-infected homosexual and bisexual men with hairy leukoplakia and oral candidiasis. AIDS. 1992 Jan; 6(1):95-100. Katz MH, Greenspan D, Westenhouse J, Hessol NA, Buchbinder SP, Lifson AR, Shiboski S, Osmond D, Moss A, Samuel M, et al. PMID: 1543572.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    203. The association of clinical conditions and serologic tests with CD4+ lymphocyte counts in HIV-infected subjects without AIDS. AIDS. 1991 Oct; 5(10):1209-15. Lifson AR, Hessol NA, Buchbinder SP, Holmberg SD. PMID: 1686178.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    204. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS. 1991 May; 5(5):519-25. Feigal DW, Katz MH, Greenspan D, Westenhouse J, Winkelstein W, Lang W, Samuel M, Buchbinder SP, Hessol NA, Lifson AR, et al. PMID: 1863403.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    205. Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: immunologic and virologic characteristics. J Infect Dis. 1991 May; 163(5):959-65. Lifson AR, Buchbinder SP, Sheppard HW, Mawle AC, Wilber JC, Stanley M, Hart CE, Hessol NA, Holmberg SD. PMID: 1673465.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    206. HIV seroconversion in two homosexual men after receptive oral intercourse with ejaculation: implications for counseling concerning safe sexual practices. Am J Public Health. 1990 Dec; 80(12):1509-11. Lifson AR, O'Malley PM, Hessol NA, Buchbinder SP, Cannon L, Rutherford GW. PMID: 2240343; PMCID: PMC1405129.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    207. Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study. BMJ. 1990 Nov 24; 301(6762):1183-8. Rutherford GW, Lifson AR, Hessol NA, Darrow WW, O'Malley PM, Buchbinder SP, Barnhart JL, Bodecker TW, Cannon L, Doll LS, et al. PMID: 2261554; PMCID: PMC1664363.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    Susan's Networks
    Concepts (567)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (88)
    People in Profiles who have published with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-9-g3adcefa5 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.